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Spines are small cytoplasmic extensions of dendrites that form the postsynaptic com-
partment of the majority of excitatory synapses in the mammalian brain. Alterations in
the numerical density, size, and shape of dendritic spines have been correlated with
neuronal dysfunction in several neurological and neurodevelopmental disorders associated
with intellectual disability, including Rett syndrome (RTT). RTT is a progressive neurodevel-
opmental disorder associated with intellectual disability that is caused by loss of function
mutations in the transcriptional regulator methyl CpG-binding protein 2 (MECP2). Here, we
review the evidence demonstrating that principal neurons in RTT individuals and Mecp2-
based experimental models exhibit alterations in the number and morphology of dendritic
spines. We also discuss the exciting possibility that signaling pathways downstream of
brain-derived neurotrophic factor (BDNF), which is transcriptionally regulated by MeCP2,
offer promising therapeutic options for modulating dendritic spine development and
plasticity in RTT and other MECP2-associated neurodevelopmental disorders.
Keywords: MeCP2, BDNF, excitatory synapse, spine density, hippocampus, organotypic slice cultures,TrkB, autism
spectrum disorder
INTRODUCTION
Espinas dendríticas are small cytoplasmic extensions emerging
from the dendrites of neurons that were ﬁrst described in the
cerebellum and cerebrum of birds and mammals by Santiago
Ramón y Cajal at the end of the 19th century (Ramón y Cajal,
1888, 1891b, 1896; as cited in Yuste, 2010). Cajal had already envi-
sioned that dendritic spines are contacted by axons at synapses
(Ramón y Cajal, 1891a, 1894), and used this arrangement as the
main example in support of hisNeuronal Doctrine (Ramón yCajal,
1933). With the aid of electron microscopy and confocal ﬂuores-
cence microscopy, it is now well established that spines are the
postsynaptic sites of most excitatory synapses in the brain, receiv-
ing inputs from glutamatergic axons (Bhatt et al., 2009; Yuste,
2010; Shirao and Gonzalez-Billault, 2013). Despite their small
size (∼1 μm in diameter), proper dendritic spine formation is
critical for brain function. Numerous proteins, including neu-
rotransmitter and neuropeptide receptors, signaling kinases, and
phosphatases, as well as ion channels are expressed in dendritic
spines, where they participate in excitatory synaptic transmis-
sion and activity-dependent synaptic plasticity, and ultimately
in learning and memory (Sala and Segal, 2014). During devel-
opment and throughout adulthood, the numerical density and
morphology of individual spines are critical for the ﬁne-tuning
of neuronal and synaptic excitability, allowing the initial estab-
lishment and activity-dependent remodeling of connectivity of
neuronal circuits (Luebke et al., 2010).
The morphology of dendritic spines is highly variable, and by
deﬁning the biochemical and electrical properties of the postsy-
naptic compartment, it contributes to the strength andplasticity of
excitatory synapses (Luebke et al., 2010). Spines have been broadly
classiﬁed into three morphological types: stubby, mushroom and
thin (Peters and Kaiserman-Abramof, 1969). Mushroom spines
have a large head that is connected to the parent dendrite through
a narrow neck. Stubby spines do not have a noticeable neck
and are most common during postnatal development (Chapleau
et al., 2009b; Rochefort and Konnerth, 2012). These two types
of large spines are referred to as “memory spines,” because they
are stable, persist for longer periods of time, and are the post-
synaptic side of strong excitatory synapses (Trachtenberg et al.,
2002; Kasai et al., 2003). Conversely, thin spines have a thin,
long neck, and a small bulbous head, are highly motile, unsta-
ble, and often short-lived, usually representing weak or silent
synapses (Rochefort and Konnerth, 2012). Because thin spines
are more plastic than large spines and have the potential to
become stable spines, they have been dubbed “learning spines”
(Grutzendler et al., 2002; Trachtenberg et al., 2002; Kasai et al.,
2003; Holtmaat et al., 2005). It should be noted that thin protru-
sions longer than thin spines and without a noticeable head are
called dendritic ﬁlopodia, and are more numerous than spines in
developing neurons. Dendritic ﬁlopodia are transient and highly
motile protrusions that can receive synaptic input anddevelop into
mature spines, thus initiating synaptogenesis (Fiala et al., 1998;
Luebke et al., 2010).
Following thewell-known relationship between formand func-
tion in biological systems, recent in vitro and in vivo studies
have demonstrated that the morphology of spines relates closely
to the function and plasticity of the synapses they belong to
(Yuste et al., 2000; Trachtenberg et al., 2002; Mizrahi et al., 2004;
Segal, 2005; Kasai et al., 2010). For example, the volume of the
spine head is directly proportional to the area of the postsy-
naptic density and the number of synaptic vesicles docked at
the presynaptic active zone (Harris and Stevens, 1989; Schiko-
rski and Stevens, 1999), the number of postsynaptic receptors
(Nusser et al., 1998), and hence to the size of synaptic currents
and synaptic strength (Yuste and Bonhoeffer, 2001; Luebke et al.,
2010). Two-photon uncaging of glutamate on large spines evoked
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larger postsynaptic currents mediated by AMPA receptors than
uncaging on small spines (Matsuzaki et al., 2001; Kasai et al., 2010).
Such a structure-function relationship is also evident in the intra-
cellular Ca2+ signals within spines triggered by afferent synaptic
activity (Yuste et al., 2000; Nimchinsky et al., 2002; Bloodgood and
Sabatini, 2007). Together with structural changes in response to
afferent synaptic stimulation (Murphy and Segal, 1996; Srivas-
tava and Penzes, 2011), all these ﬁndings support the long held
view that dendritic spines are the morphological substrate of neu-
ronal plasticity and learning and memory (Sala and Segal, 2014).
In support of this notion, induction of long-term potentiation
(LTP) leads to spine enlargement (Matsuzaki et al., 2004; Park
et al., 2006), whereas long-term depression (LTD) causes spine
shrinkage (Nagerl et al., 2004; Zhou et al., 2004; Hoogenraad and
Akhmanova, 2010; Penzes et al., 2011b).
The relationship between dendritic spines and cognitive abil-
ities was noted in early studies, when the term “spine dysge-
nesis” was coined by Dominick Purpura (Huttenlocher, 1970;
Marin-Padilla, 1972; Purpura, 1974). Such anomalies in the
morphology – and likely function – of dendritic spines have been
described in several neurological disorders associated with cogni-
tive decline, including typical aging, Alzheimer’s and Huntington
diseases, schizophrenia, neurodevelopmental intellectual disabil-
ities, and autism spectrum disorders (Fiala et al., 2002; Fukuda
et al., 2005; Zhao et al., 2007; Bourgeron, 2009; Chapleau et al.,
2009b; Garey, 2010; Penzes et al., 2011a; Levenga and Willemsen,
2012).
DENDRITIC SPINE DYSGENESIS IN RETT SYNDROME
Rett syndrome (RTT) is an X-linked progressive autism spec-
trum disorder associated with intellectual disability that affects
girls during early childhood (∼1:15,000 birth worldwide; Neul
and Zoghbi, 2004; Chapleau et al., 2009b). The disorder is char-
acterized by a seemingly typical development for 6 to 18 months
followed by regression and onset of a variety of neurological fea-
tures, including motor impairments, loss of acquired language,
intellectual disability, seizures, and anxiety (Chahrour andZoghbi,
2007). The majority of RTT individuals carry loss-of-function
mutations in MECP2, the gene encoding methyl CpG-binding
protein 2 (MeCP2), a global transcriptional regulator that binds
to methylated CpG sites in promoter regions of DNA (Amir et al.,
1999; Chahrour et al., 2008). Emerging evidence indicates that
RTT results from a deﬁcit in synaptic maturation in the brain, and
that MeCP2 plays a critical role in neuronal and synaptic matura-
tion and pruning during development (Cohen et al., 2003; Calfa
et al., 2011b), as well as in the function of established neuronal
networks in adulthood (McGraw et al., 2011).
Pyramidal neurons in the cortex and hippocampus of RTT
individuals have dendrites with atypical morphology (Belichenko
et al., 1994; Armstrong et al., 1995; Chapleau et al., 2009a;
Figure 1A). Two different mouse models lacking Mecp2 (Chen
et al., 2001; Guy et al., 2001) have reduced dendritic complex-
ity (Fukuda et al., 2005; Nguyen et al., 2012; Stuss et al., 2012),
and decreased dendritic spine density and motility in cortical
and hippocampal neurons (Belichenko et al., 2009; Tropea et al.,
2009; Landi et al., 2011; Chapleau et al., 2012; Castro et al., 2014).
On the other hand, Mecp2308 mice expressing truncated MeCP2
(Shahbazian et al., 2002), which have impaired synaptic plasticity
and hippocampal-dependent learning and memory and other
RTT-related neurological deﬁcits, do not show any dendritic or
synaptic anomalies neither in cortical nor hippocampal neurons
(Moretti et al., 2006). The reduced dendritic spine density, along
with a decrease in the proportion of mushroom spines, is also
present in primary hippocampal neurons (Chao et al., 2007; Baj
et al., 2014) and hippocampal slice cultures (Figure 1B) prepared
from newborn Mecp2 knockout (KO) pups, as well as in neurons
derived from induced pluripotent stem cells obtained from RTT
individuals (Marchetto et al., 2010).
The spine dysgenesis phenotype in pyramidal neurons of the
hippocampus in Mecp2 KO mice has revealed unexpected com-
plexities. CA1 and CA3 pyramidal neurons have lower spine
density only in neonatal (postnatal day-7) Mecp2 KOs, well before
excitatory synapse expansion. Spine density reaches wildtype
(WT) levels a week later (postnatal day-15), and is maintained
at WT levels throughout the symptomatic stage (postnatal day-
40 to 60). Quantitative electron microscopy conﬁrmed that the
density of asymmetric spine synapses in CA1 stratum radiatum
of Mecp2 KOs is comparable to that of WT mice (Calfa et al.,
2011a; Chapleau et al., 2012). This developmental progression
of the spine density phenotype is also reﬂected in the density
of excitatory synapses imaged as VGLUT1-PSD95 immunoﬂu-
orescent puncta, which is lower in area CA1 of 2 week-old
Mecp2 null mice, but comparable to WT levels at 5 weeks
of age (Chao et al., 2007). Altogether, these data demonstrate
that proper MeCP2 functioning is required for dendritic spine
formation during early postnatal development, and that a sec-
ondary compensatory mechanism seems to take place during
atypical development in Mecp2 KOs. A couple of possibili-
ties exist as to the extent of the compensatory mechanisms
necessary to bring spine density to WT levels in hippocam-
pal neurons. One possibility is that enhanced hippocampal
network activity in Mecp2 KOs promotes dendritic spine forma-
tion (Calfa et al., 2011a). A second possibility is that deranged
homeostatic plasticity promotes spinogenesis, while still affect-
ing pyramidal neuron function (Blackman et al., 2012; Qiu et al.,
2012).
Consistent with a model that tightly regulated MeCP2 levels are
necessary during brain development and adulthood, overexpres-
sion of Mecp2 in vitro or in the MECP2 duplication mouse model
(Mecp2Tg1) either increased (Jugloff et al., 2005; Chao et al., 2007;
Jiang et al., 2013) or decreased (Zhou et al., 2006; Chapleau et al.,
2009a; Cheng et al., 2014) dendritic complexity, spine density, and
the density of excitatory synapses. Table 1 sumarizes all the pub-
lished work on dendritic spines in RTT and experimenal models
based on MeCP2 loss-of-function.
ROLE OF BDNF IN DENDRITIC SPINE FORMATION AND
PLASTICITY: A POTENTIAL THERAPY FOR RTT
MeCP2 regulates the expression of thousands of genes, includ-
ing brain-derived neurotrophic factor (Bdnf; Chen et al., 2003;
Martinowich et al., 2003; Zhou et al., 2006). BDNF is well known
to promote neuronal and synaptic maturation (Carvalho et al.,
2008), increase dendritic spine density, and enhance synaptic plas-
ticity and learning and memory (Figurov et al., 1996; Luine and
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FIGURE 1 | Dendritic spine dysgenesis in Rett syndrome, and
intracellular signaling cascades involved in spine plasticity mediated by
BDNF and IGF-1. (A) Confocal images of human CA1 pyramidal neurons in
hippocampal sections from autopsy material labeled with DiI. Neurons from
RTT individuals have lower dendritic spine density than those from typically
developing individuals (Non-ID, non-intellectually disabled). **P < 0.01
(adapted from Chapleau et al., 2009a). (B) Confocal images of apical
dendritic segments (top) of eYFP-expressing CA1 pyramidal neurons in
11 days in vitro hippocampal slice cultures prepared from postnatal day-5
wildtype (WT) and Mecp2 knockout (KO) mice, and their corresponding
surface-rendered reconstructions (bottom). (C) Schematic diagram of an
exemplary excitatory synapse on a dendritic spine of a pyramidal neuron in
the hippocampus. We highlight the intracellular signaling cascades that
mediate the effects of BDNF and IGF-1 on structural plasticity of spines.
TrkB receptors are activated upon binding of BDNF, leading to dimerization
and auto-phosphorylation. This process allows for the binding of adaptor
proteins to their intracellular domain, and the subsequent activation of
Ras/ERK, PI3K, and PLCγ (reviewed by Huang and Reichardt, 2003). All
these pathways have been implicated in the effects of BDNF on dendritic
spines (highlighted in red, see text for references). Potential therapies for
the treatment of RTT act on these pathways (highlighted in green, see text
for details and references): LM22A-4 binds and activates TrkB receptors
directly (Massa et al., 2010); activation of IGF-1 receptors triggers the PI3K
and Ras/ERK signaling pathways (Zheng and Quirion, 2004). DCV, dense
core vesicle; Glu, glutamate; AMPAR, α-amino-3-hydroxy-5-methyl-
4-isoxazolepropionic acid receptor; NMDAR, N -methyl-D-aspartate receptor;
mGluR, metabotropic glutamate receptor; ER, endoplasmic reticulum; RyR,
ryanodine receptor; PIP2, phosphatidylinositol 4,5 bisphosphate; DAG,
diacylglycerol; IP3, inositol triphosphate; IP3R, IP3 receptor; PKC, protein
kinase C; SH-2, src homology domain 2; SHC, SH-2-containing protein;
Grb2, growth factor receptor-binding protein 2; GAB1, Grb2-associated-
binding protein 1; SOS, nucleotide exchange factor son-of-sevenless; Frs2,
ﬁbroblast growth factor receptor substrate 2; AKT, protein kinase B; Ras, rat
sarcoma proto-oncogenic G-protein; Raf, proto-oncogenic serine/threonine
protein kinase; MAPK, mitogen-activated protein kinase; MEK, MAPK
kinase; cAMP, cyclic adenosine monophosphate; CREB, cAMP response
element-binding protein; IGF-1R, IGF-1 receptor; IRS-1, insulin receptor
substrate 1.
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Table 1 | Dendritic spine dysgenesis in RTT individuals and MeCP2-deficient cells and mice.
Source Brain region Preparation Alterations in dendrites and
dendritic spines
Reference




Belichenko et al. (1994),
Armstrong et al. (1995)
Hippocampus Fixed postmortem brain (CA1 region at
1–42 years old)
↓Dendritic spine density Chapleau et al. (2009a)
Induced pluripotent
stem cells




Marchetto et al. (2010)
Mecp2tm.1.1Bird Cortex Fixed brain (layer II/III motor cortex at P21) ↓Dendritic spine density Belichenko et al. (2009)




Fukuda et al. (2005)
Hippocampus Autaptic culture (DIV7–9) ↓Excitatory synapse number Chao et al. (2007)





Baj et al. (2014)
Fixed brain (CA1 region at P21) ↓Dendritic spine density Belichenko et al. (2009)
Fixed brain (CA1 region at P42) ↓Dendritic complexity
↓Dendritic spine density
Nguyen et al. (2012)
Fascia dentata Fixed brain (P21) ↓Dendritic spine density Belichenko et al. (2009)
Mecp2tm.1.1Jae Cortex In vivo and ﬁxed brain (layer V somatosensory
cortex at P25, P40)
↓Dendritic spine density
altered spine dynamics
Landi et al. (2011)
Fixed brain (layer V motor cortex at P40) ↓Dendritic complexity
↓Dendritic spine density
Stuss et al. (2012)
Fixed brain (layer II/III visual cortex at P42) ↓Dendritic spine density Castro et al. (2014)
Fixed brain (layer V motor cortex at P60) ↓Dendritic spine density Tropea et al. (2009)
Hippocampus Fixed brain (CA1 region at P7) ↓Dendritic spine density Chapleau et al. (2012)
Fixed brain (CA1 region at P21) ↓Dendritic spine density Belichenko et al. (2009)
Fixed brain (newly matured DG neurons at P56) ↓Dendritic spine density Smrt et al. (2007)
Mecp2
knockdown
Cortex Primary culture (layer II/III visual cortex at
DIV7-9)
↓Excitatory synapse number Blackman et al. (2012)
Hippocampus Slice culture (CA1 region at DIV11) ↓Dendritic spine density
↓Mature spines
Chapleau et al. (2009a)
Mecp2Tg1 Cortex In vivo (layer V somatosensory cortex at P56) ↑Dendritic spine density Jiang et al. (2013)
Hippocampus Autaptic culture (DIV7–9) ↑Excitatory synapse number Chao et al. (2007)
Overexpression
of MECP2
Cortex Primary culture (DIV6) ↑Dendritic complexity Jugloff et al. (2005)
Primary culture (DIV6) ↓Dendritic complexity Cheng et al. (2014)
Hippocampus Slice culture (pyramidal neurons at DIV7) ↓Dendritic complexity
↑Thin spines
Zhou et al. (2006)
Slice culture (pyramidal neurons at DIV9) ↓Dendritic complexity
↓Dendritic spine density
Cheng et al. (2014)
Slice culture (CA1 region at DIV9) ↓Dendritic spine density
↓Mature spines




Hippocampus Slice culture (CA1 region at DIV9–11) ↓Dendritic spine density
↓Mature spines
Chapleau et al. (2009a)
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Frankfurt, 2013). MeCP2 binds to the Bdnf promoter and modu-
latesBdnf expression in an activity-dependentmanner (Chen et al.,
2003; Martinowich et al., 2003; Zhou et al., 2006; Chahrour and
Zoghbi, 2007). Lower Bdnf mRNA and BDNF protein levels, as
well as impaired BDNF trafﬁcking and activity-dependent release,
have been highlighted as pathophysiological mechanisms of RTT
disease progression (Chang et al., 2006; Wang et al., 2006; Ogier
et al., 2007; Li et al., 2012; Xu et al., 2014). Indeed, overexpression
of BDNF rescues several cellular and behavioral deﬁcits in Mecp2
KO mice (Chang et al., 2006; Chahrour and Zoghbi, 2007). These
studies indicate that BDNF plays a critical role in neurological
impairments in MeCP2-deﬁcient mice.
Several studies have demonstrated that BDNF participates
in synaptic plasticity, and is critical for dendritic spine for-
mation and maturation during development (Poo, 2001; Tyler
et al., 2002a; Tanaka et al., 2008; Cohen-Cory et al., 2010; Vigers
et al., 2012). For example, exogenously applied BDNF increases
spine density in cultured hippocampal neurons and CA1 pyra-
midal neurons in slice cultures (Tyler and Pozzo-Miller, 2001; Ji
et al., 2005). In addition, BDNF shifts the proportions of mor-
phological types of spines in hippocampal slice cultures (Tyler
and Pozzo-Miller, 2003; Chapleau et al., 2008). Moreover, over-
expression of the Bdnf gene in cultured hippocampal neurons
rescued the dendritic atrophy caused by shRNA-mediated Mecp2
knockdown (Larimore et al., 2009). These effects of BDNF on
dendritic spines are mediated by the tropomyosin related kinase
B (TrkB) receptor (Tyler and Pozzo-Miller, 2001), and subsequent
activation of extracellular signal-regulated kinase (ERK; Alonso
et al., 2004), phosphatidylinositol 3-kinase (PI3K; Kumar et al.,
2005), and phospholipase C-γ (PLC-γ), which leads to the open-
ing of canonical transient receptor potential (TRPC) channels
containing the TRPC3 subunit (Amaral and Pozzo-Miller, 2007;
Chapleau et al., 2009b; Li et al., 2012; Luine and Frankfurt, 2013;
Figure 1C).
Activity-dependent release of endogenously expressed (native)
BDNF also modulates spine morphology in conjunction with
spontaneous neurotransmitter release (Tyler et al., 2002b; Tyler
and Pozzo-Miller, 2003; Tanaka et al., 2008). In addition, proper
secretory trafﬁcking of BDNF is essential for its actions on den-
dritic spine development and plasticity. The human BDNF gene
has a single nucleotide polymorphism – a methionine (met)
substitution for valine (val) at codon 66 – that impairs BDNF
trafﬁcking and its activity-dependent release, resulting in cogni-
tive dysfunction in the general population (Egan et al., 2003; Chen
et al., 2004), as well as more severe neurological symptoms in RTT
individuals (Zeev et al., 2009). Consistently, dendritic complex-
ity is reduced in dentate granule cells of Val66Met knock-in mice
(Chen et al., 2006). Therefore, expression of this BDNF polymor-
phism might lead to deleterious effects on dendritic spine density
and morphology.
The main limitation of BDNF-based therapies for neurological
disorders, including RTT, is its poor blood-brain barrier perme-
ability. Synthetic BDNF-loop mimetics with selective TrkB agonist
activity are exciting alternatives (Massa et al., 2010; Kajiya et al.,
2014). Indeed, systemic treatment with LM22A-4 rescues respi-
ratory deﬁcits in female Mecp2 heterozygous mice (Schmid et al.,
2012), and prevents spine loss in striatal medium-spiny neurons
in a mouse model of Huntington’s, rescuing their motor deﬁcits
(Simmons et al., 2013).
Other intriguing substitutes for BDNF are insulin-like growth
factor-1 (IGF-1) and its active tripeptide ([1–3]IGF-1, also known
as glypromate, GPE), a hormone widely expressed in the CNS
during brain development that promotes neuronal survival as
well as synaptic maturation (D’Ercole, 1996; O’Kusky et al., 2000;
Tropea et al., 2009). Indeed, systemic treatment of male Mecp2 KO
mice with [1–3]IGF-1 signiﬁcantly increased activity of signal-
ing pathways downstream of TrkB and improved several RTT-like
symptoms and increased dendritic spine density in cortical neu-
rons (Tropea et al., 2009), effects that are all recapitulated by
full-length IGF-1 (Castro et al., 2014). These effects are due to
the activation of IGF-1 receptors directly by IGF-1, and indirectly
by [1–3]IGF-1, which does not bind to the IGF-1 receptor but
rather increases the expression of IGF-1 (Carlsson-Skwirut et al.,
1989; Corvin et al., 2012). It should be noted that full-length IGF-1
worsened a metabolic syndrome in Mecp2 KO mice, and did not
affect dendritic spine density in hippocampal neurons (Pitcher
et al., 2013). The safety and efﬁcacy of recombinant human full-
length IGF-1 (mecasermin) in a Phase-1 clinical trial in RTT
individuals have been recently reported (Khwaja et al., 2014). The
[1–3]IGF-1 analog glycyl-L-methylprolyl-L-glutamic acid (NNZ-
2566; Neuren Pharmaceuticals) is in a Phase-2 clinical trial in RTT
individuals.
CONCLUSION
Activity-dependent plasticity of dendritic spines includes both
the formation of new spines and their maturation from thin,
ﬁlipodia-like protrusions to “memory spines” that accompany
excitatory synapse formation during brain development, as well
as the structural remodeling of already existing spines. Alterations
in neuronal circuitry are due to, or at least reﬂected by, deﬁcits in
dendritic spine structure and function. Dendritic spine anoma-
lies have been identiﬁed in multiple brain regions in RTT and
Mecp2-based mouse models. Since BDNF promotes the forma-
tion, maintenance, and activity-dependent sculpting of dendritic
spines, and plays a critical role in neurological dysfunction in RTT,
it emerges as one of the most exciting therapeutic agents for RTT.
Thus, treatments that target the BDNF receptor TrkB and/or its
downstream signaling pathways stand out as strong candidates to
improve not only the spine dysgenesis phenotype, but also other
synaptic plasticity deﬁcits in RTT and other neurodevelopmental
disorders caused by impaired BDNF availability.
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